Connection

Michael Lilly to Anticarcinogenic Agents

Back to Details
This is a "connection" page, showing publications Michael Lilly has written about Anticarcinogenic Agents.
Michael Lilly
Connection Strength
0.134
Anticarcinogenic Agents
  1. Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model. Oncotarget. 2015 Dec 08; 6(39):41809-24.
    View in: PubMed
    Score: 0.134
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.